Modern Dental Group (3600) Announces Nine-Month 2025 Results with 9.2% Revenue Growth

Bulletin Express
2025/11/27

Modern Dental Group (3600) reported that total revenue for the nine months ended 30 September 2025 reached approximately HK$2,752.4 million, marking a 9.2% increase from the HK$2,521.6 million recorded in the same period of 2024. This performance took place despite international trade uncertainties and generally softer demand for dental procedures.

Modern Dental Group attributed the results to multi-dimensional strategies, operational efficiency gains, and the ongoing adoption of digitalization initiatives in the dental industry. By leveraging production facilities in Thailand, Vietnam, and Mainland China, the company sought to enhance competitiveness and successfully expand its market share.

In terms of regional performance, Europe’s revenue increased to HK$1,365.5 million (+2.8% in currency terms, +10.7% in original currency). North America’s revenue decreased to HK$534.4 million, impacted by weaker cosmetic treatment demand, although offshore-made products in the region recorded growth. Greater China’s revenue amounted to HK$455.0 million, constrained by volume-based procurement policies and intense price competition. Australia’s revenue rose to HK$215.0 million (-3.4% in currency terms, +12.8% in original currency). The “Others” category reached HK$182.5 million, primarily driven by the acquisition of Hexa Ceram in January 2025, which contributed HK$137.9 million.

Overall sales volumes grew 29.5% to about 2,115,000 cases. Excluding the additional 456,000 cases from Hexa Ceram, sales volumes increased by approximately 1.6% year on year. Digital solution cases rose to 698,000, reflecting a 24.4% jump from the previous comparable period. The average selling price was HK$1,227 per case, representing a 14.9% decline from HK$1,442, mainly due to the addition of Hexa Ceram. Excluding Hexa Ceram, the average selling price was HK$1,474 per case, roughly in line with the year before.

According to Modern Dental Group, these figures are based on preliminary management accounts and have not been audited. The unaudited operational data should be reviewed alongside the most recent annual and interim reports. The foundation of the company’s strategies remains focused on reinforcing international market presence and maintaining a prudent approach amid evolving industry and economic conditions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10